Treatment Guidelines for Medical Providers

Hidradenitis Suppurativa is a chronic, debilitating, inflammatory disease, which affects up to 1% of the U.S. population. The following guidelines are based on current evidence and practice trends, emphasizing the role of dermatologists in treatment recommendations.

Access the full hidradenitis suppurativa guideline from JAAD (free):

• Part I: Diagnosis, evaluation, and the use of complementary and procedural management
• Part II: Topical, intralesional, and systemic medical management
• Supplemental Materials: Background and recommendations regarding use of systemic antibiotics, biologics, and systemic retinoids for Hidradenitis Suppurativa